Search Results - "RICO Study Group"

Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.

Authors: Bidar, Frank Hamada, Sarah Gossez, Morgane et al.

Source: Annals of Intensive Care. 4/1/2022, Vol. 12 Issue 1, p1-12. 12p.

Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.

Authors: Bidar, Frank Hamada, Sarah Gossez, Morgane et al.

Source: Annals of Intensive Care. 3/5/2022, Vol. 12 Issue 1, p1-12. 12p.

Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.

Authors: Bidar, Frank Hamada, Sarah Gossez, Morgane et al.

Source: Annals of Intensive Care. 3/4/2022, Vol. 12 Issue 1, p1-12. 12p.

Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.

Authors: Bidar, Frank Hamada, Sarah Gossez, Morgane et al.

Source: Annals of Intensive Care. 4/1/2022, Vol. 12 Issue 1, p1-3. 3p.